People · Operator

Suraj S. Kalia

Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology

1
Companies
4
Filings
$21.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NEUROONE MEDICAL TECHNOLOGIES CorpBiotechnologySeries A$21.2M$1.4M2017
Operator network

Suraj S. Kalia at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David A. Rosa · 5 companies · 1 sharedDavid A. RosaJEFFREY S. MATHIESEN · 4 companies · 1 sharedJEFFREY S. MATHIE…Paul A Buckman · 3 companies · 1 sharedPaul A BuckmanMark A. Christianson · 2 companies · 1 sharedMark A. Christian…Paul S. Buckman · 2 companies · 1 sharedPaul S. BuckmanRonald A. McClurg · 2 companies · 1 sharedRonald A. McClurgSuraj A. Kalia · 2 companies · 1 sharedSuraj A. KaliaThomas A. Bachinski · 2 companies · 1 sharedThomas A. Bachins…Christopher A. Volker · 1 companies · 1 sharedChristopher A. Vo…Edward A. Andrle · 1 companies · 1 sharedEdward A. AndrleMark S. Christianson · 1 companies · 1 sharedMark S. Christian…Ronald S. McClurg · 1 companies · 1 sharedRonald S. McClurgSteve A. Mertens · 1 companies · 1 sharedSteve A. MertensNEUROONE MEDICAL TECHNOLOGIES Corp · $21.2M raisedNEUROONE MEDICAL TECH…Suraj S. KaliaSK
Suraj S. Kalia Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Suraj S. Kalia on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David A. Rosa15
JEFFREY S. MATHIESEN14
Paul A Buckman13
Mark A. Christianson12
Paul S. Buckman12
Ronald A. McClurg12
Suraj A. Kalia12
Thomas A. Bachinski12
Christopher A. Volker11
Ronald S. McClurg11
Mark S. Christianson11
Edward A. Andrle11
Steve A. Mertens11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.